Related Experiment Videos
Usefulness of thallium-201 re-injection method for the evaluation of myocardial viability
1Second Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Insights
The re-injection method improves the detection of myocardial viability in patients with coronary artery disease. This technique enhances the accuracy of thallium myocardial scintigraphy, preventing underestimation of viable heart tissue.
Area of Science:
- Cardiology
- Nuclear Medicine
- Medical Imaging
Background:
- Exercise thallium myocardial scintigraphy can underestimate myocardial viability in coronary artery disease patients.
- Persistent thallium defects may not always indicate irreversible myocardial damage.
- Coronary revascularization can restore function in previously underestimated viable myocardium.
Observation:
- A novel "re-injection method" was developed to improve the assessment of myocardial viability.
- Thallium was injected at peak exercise, with conventional delayed imaging and a subsequent re-injection imaging protocol.
- Images were analyzed using single photon emission computed tomography (SPECT) and compared to ventriculography and coronary angiography.
Findings:
- The re-injection method identified significantly more redistribution segments (49%) compared to delayed imaging alone (38%).
- Myocardial viability was more accurately assessed in normokinetic and hypokinetic segments using the re-injection technique.
- No significant difference was observed in akinetic segments, suggesting the method is most beneficial for potentially viable, dysfunctional myocardium.
Implications:
- The re-injection method offers improved accuracy in detecting myocardial viability, crucial for treatment decisions.
- This technique helps avoid underestimation of viable heart muscle, leading to more appropriate revascularization strategies.
- Enhanced detection of myocardial viability can optimize patient outcomes in coronary artery disease management.
Abstract:
Areas of the heart which are supposedly absent of myocardial viability due to persistent thallium defect in exercise thallium myocardial scintigraphy sometimes recover ventricular wall motion through coronary revascularization. To avoid such underestimation of myocardial viability, a "re-injection method" was developed. At the peak of supine ergometer exercise in 51 patients with coronary artery disease, 111 MBq thallium was injected. Conventional exercise and 3 h-delay images were then obtained using single photon emission computed tomography. Subsequently, 55 MBq thallium was injected and a re-injection image was obtained 1 h later. Each image was divided into 12 segments and compared by left ventriculography and coronary angiography. Redistribution was found in 36 patients (71%) on the delayed images and in 44 patients (86%) on either the delayed or the re-injection images (p < 0.05). There were 127 redistribution segments (38%) on the delayed images and 163 (49%) on the re-injection images out of 336 defects on the exercise images (p < 0.001). In normokinetic segments with significant coronary stenosis and in hypokinetic segments, redistribution was found in 42% and 45% of the defects, respectively, on the delayed images, and in 65% and 62% of the defects, respectively, on the re-injection images (p < 0.01). However, no significant differences were observed between the delayed and either the delayed or re-injection images in the akinetic segments. These results suggest that the re-injection method is useful for avoiding underestimation of myocardial viability.